Shed vs Hims for Weight Loss: Real Cost, Cancellation, and Who Each Fits in 2026

By Weight Loss Provider Guide Editorial Team · Published April 18, 2026 · Last verified April 18, 2026 · Full disclosure ↓

Independent comparison resource. We earn a commission on both Shed and Hims referrals. Where Hims wins, we say so plainly — see the cost matrix and cancellation section below.

Major change, March 9, 2026: Hims & Hers signed a partnership with Novo Nordisk to distribute FDA-approved Wegovy and Ozempic, and agreed to stop advertising compounded GLP-1s at scale. Comparisons published before mid-March 2026 are out of date. Full timeline ↓

For most self-pay readers comparing Shed vs Hims for weight loss, Shed is the better fit — you get a weight-loss-specific provider, more medication formats (injections, sublingual drops, lozenges, oral tablets, and the FDA-approved Foundayo pill added to Shed’s platform on April 15, 2026), direct HSA/FSA checkout, and a refund-or-credit option tied to Shed’s 10%-weight-loss program if you meet the terms. Pick Hims instead if you specifically want branded Wegovy or Ozempic through a publicly traded telehealth with a direct Novo Nordisk supply agreement, or if cancel-anytime is your primary filter.

The catch most comparison pages miss: Hims’ medication price is not the whole price, and both Shed and Hims currently show pricing inconsistencies across their own public pages. We pulled both. Everything below is tied to a source and dated. Where a provider’s own pages conflict, we show you both numbers so you can verify at intake and walk in with eyes open.

The 30-second verdict: Shed vs Hims at a glance

Quick-fit decision guide: Shed vs Hims for weight loss 2026
If you want…PickWhy
Compounded semaglutide or tirzepatideShedHims exited mass-market compounded advertising in March 2026; Shed didn't
A pill and no injectionsShedFoundayo, Wegovy pill, lozenges, drops — Hims has the Wegovy pill only
Direct HSA/FSA card at checkoutShedHims' guidance is typically a reimbursement workflow
Cheapest verified first-month branded path ($188 all-in)Hims Wegovy Pill$149 medication + $39 first-month membership
A 10% weight-loss refund/credit optionShedWith program requirements — see cancellation section. Hims offers no equivalent.
Cancel-anytime with no minimum termHimsShed requires a 2-month minimum and 72-hour notice to cancel
Brand recognition and a publicly traded parentHimsNYSE: HIMS, direct Novo Nordisk supply agreement signed March 9, 2026
Check Shed eligibility and see real pricing →See current Hims pricing and membership →
Shed vs Hims GLP-1 weight loss path comparison infographic: Choose Shed if you want more GLP-1 format options, non-injection choices, direct HSA/FSA checkout, a weight-loss-focused platform, and route flexibility. Choose Hims if you want a polished app-first experience, branded GLP-1 options, a cleaner membership structure, easier cancellation, and mainstream telehealth brand recognition.

Editorial infographic showing decision factors for both providers. Compounded medications are not FDA-approved as finished products.

What changed in March 2026 — and why older comparisons are wrong

The headline: On March 9, 2026, Hims & Hers signed a strategic partnership with Novo Nordisk to distribute FDA-approved Wegovy and Ozempic through the Hims platform. In exchange, Hims agreed to stop advertising and marketing compounded GLP-1 medications at scale, transition existing compounded customers to FDA-approved alternatives where clinically appropriate, and keep compounded access only for the small number of cases a provider determines it’s necessary.

The full timeline

Timeline of regulatory and business changes affecting Hims GLP-1 programs, February–April 2026
DateEvent
Sept 9, 2025FDA issued a warning letter to Hims & Hers for marketing claims about compounded semaglutide (Warning Letter 716567-09092025)
Feb 5, 2026Hims announced a $49 compounded oral semaglutide pill. Novo Nordisk threatened a patent-infringement lawsuit within hours.
Within daysHims pulled the $49 pill under FDA and Novo Nordisk pressure.
Feb 2026FDA issued a public statement: companies cannot promote non-FDA-approved compounded products as equivalents or copies of FDA-approved drugs.
Mar 3, 2026FDA released 30 warning letters to telehealth companies over compounded GLP-1 marketing.
Mar 9, 2026Hims and Novo Nordisk resolved the dispute with a new partnership. Novo dropped the lawsuit. Hims agreed to stop advertising compounded GLP-1s at scale.
Apr 1, 2026FDA approved Foundayo™ (orforglipron), the first non-peptide oral GLP-1 for weight management (Eli Lilly).
Apr 15, 2026Shed added Foundayo to its platform. Hims has not listed Foundayo as of our April 18, 2026 verification date.
What this means right now: If compounded is what you want, Hims is effectively out of that category for new enrollments. If branded Wegovy or Ozempic is what you want, Hims now has a direct Novo Nordisk distribution partnership. If you want Foundayo, Shed has it. Hims does not yet.
FDA Warning Letter on file for Hims: On September 9, 2025, the FDA issued Hims & Hers a warning letter (716567-09092025) for marketing claims about compounded semaglutide. This is a documented public record. The March 2026 Novo Nordisk partnership is partly a response to this regulatory pressure. Both facts matter for an informed decision. FDA warning letter database →
Start Shed eligibility — compounded & Foundayo access →See Hims Novo Nordisk branded pricing →

What does Shed vs Hims actually cost? (Verified April 18, 2026)

Hims’ starter prices are not the whole price. Every Hims weight-loss plan requires a separate Hims Weight Loss Membership: $39 the first month, then $149/month from month two onward. So the $149 Wegovy pill becomes $188 all-in month one and ~$298/month from month two. Hims discloses this in pricing footnotes — it’s just easy to miss under headline numbers.
Woman comparing GLP-1 telehealth programs on laptop and phone, evaluating Shed vs Hims weight loss options including route preference, cost, and cancellation policies

Compare carefully: both providers show pricing inconsistencies across their own pages. Verify your exact route at intake before committing.

First-month all-in cost matrix (verified April 18, 2026)

All pricing verified on official product pages, April 18, 2026. Promotional pricing changes — confirm at intake.
RouteMedicationMembership (mo. 1)First-month totalWhat you’re buying
Hims Wegovy PillHims$149$39$188FDA-approved oral semaglutide
Hims Wegovy PenHims$199$39$238FDA-approved injectable semaglutide
Hims Generic LiraglutideHims$299$39$338FDA-approved daily injectable (older GLP-1)
Hims OzempicHims"Starting at $199/mo" on main page; retail up to $1,799 on other Hims pages — see discrepancy note$39~$238 at Novo cash-pay starterFDA-approved semaglutide (T2D-indicated; off-label for weight loss)
Shed Compounded SemaglutideShed$199 starterNone on compounded path per product page — verify at intake$199 (verify at intake)Compounded injectable, not FDA-approved as finished product
Shed Compounded TirzepatideShed$299 starterSame ambiguity — verify at intake$299 (verify at intake)Compounded injectable, not FDA-approved as finished product
Shed Wegovy (brand path)Shed$149 pill / $199 pen on one block; $349–$499 on another block$99 on one block; $125 on anotherVERIFY AT INTAKEFDA-approved via Shed brand pathway — three inconsistent price blocks
Shed FoundayoShedStarts at $149/mo per product pageProduct page notes membership separate from medicationVERIFY AT INTAKEFDA-approved oral GLP-1 pill (orforglipron) — added April 15, 2026
Both providers show pricing inconsistencies on their own public pages. On Shed: the Wegovy product page shows three different price blocks across three sections. On Hims: the main page shows Ozempic “starting at $199/mo” while other Hims pages reference $1,799/month list pricing. Both are technically accurate from different angles. Do not trust any single headline price from either provider’s marketing. Verify your exact medication, dose tier, and plan length at the intake step before committing.
After month one, Hims’ math changes. The Hims Weight Loss Membership jumps from $39 to $149/month on month two. The Hims Wegovy Pill all-in is roughly $298/month from month two — not $188. Shed’s compounded path doesn’t have a month-two membership jump, though dose escalation can raise medication cost as you titrate up. Confirm your maintenance-dose price at intake.
Start Shed’s 60-second intake and see your exact pricing →Check current Hims pricing for your route →
See all GLP-1 options under $200/month →

Which medications and formats can you actually get?

Shed offers five GLP-1 delivery formats: weekly injection (compounded or branded), sublingual drops, sublingual lozenges, compounded oral tablets, and the FDA-approved Foundayo pill (added April 15, 2026). Hims’ current weight-loss page lists the Wegovy pill, Wegovy pen, Ozempic, Mounjaro, Zepbound, and generic liraglutide, with limited compounded access only when a provider determines it’s clinically necessary.
Medication format availability verified April 18, 2026. ✓ = available; ✗ = not available or not publicly listed.
Format / MedicationShedHimsNotes
Compounded semaglutide injection✓ $199/moLimited — clinically necessary onlyHims exited mass-market compounded marketing March 2026
Compounded tirzepatide injection✓ $299/moLimited — clinically necessary onlySame Hims March 2026 shift
GLP-1 sublingual drops✓ $229/mo✗Shed only
GLP-1 sublingual lozenges✓ $199/mo✗Shed only
Compounded oral GLP-1 tablets✓ (incl. liposomal)✗Shed only
Foundayo® (orforglipron, FDA-approved)✓ from $149/mo (added Apr 15, 2026)✗ Not listed as of Apr 18, 2026FDA approved Apr 1, 2026; Shed added Apr 15
Wegovy® pill (FDA-approved)✓ Brand pathway, membership applies✓ $149/mo + $39 first-month membershipHims wins on first-month price for this format
Wegovy® pen (FDA-approved)✓ Brand pathway, membership applies✓ $199/mo + $39 first-month membershipNovo Nordisk supply via Hims
Ozempic® (FDA-approved, T2D-indicated)Not prominently listed✓ from $199/mo + membership (list: up to $1,799)Off-label for weight loss; pricing varies by plan
Zepbound® (FDA-approved)✓ from $349/mo + membership✓ list $1,899/mo + membershipShed has lower listed start price
Generic liraglutide (FDA-approved)Not listed✓ $299/mo + membershipOlder GLP-1; Hims only
Non-GLP-1 oral medication kits✗✓ from $69/mo on 10-month prepayHims only — not GLP-1 therapy

If needles are your dealbreaker

Shed has four non-injection GLP-1 options: Foundayo pill, Wegovy pill, sublingual drops, sublingual lozenges, and compounded oral tablets. Hims has the Wegovy pill and nothing else on the GLP-1 oral side. Hims’ oral kits starting at $69/month contain non-GLP-1 weight-loss medications — useful for some readers, but not GLP-1 therapy.

Compounded vs. FDA-approved: Compounded medications are prepared by licensed pharmacies and are not FDA-approved as finished products. FDA has approved semaglutide only as Ozempic®, Wegovy®, and Rybelsus®, and tirzepatide only as Mounjaro® and Zepbound®. FDA’s February 2026 statement emphasized that companies cannot market non-FDA-approved compounded products as equivalents to FDA-approved drugs. Pages that treat compounded and FDA-approved as interchangeable are not serving you well.
See Shed’s full format menu and check state availability →See Hims branded Wegovy and Ozempic routes →

Who should pick Shed, who should pick Hims, and who should pick neither?

Pick Shed if:

  • You want to start or stay on compounded semaglutide or tirzepatide
  • Your top priority is avoiding injections — Shed has four non-injection GLP-1 options
  • You want Foundayo, the FDA-approved oral GLP-1 pill
  • You want a weight-loss-specific provider rather than a multi-category telehealth brand
  • Direct HSA/FSA card checkout matters to you
  • The lowest compounded monthly cost without bundling a separate membership fee is a deal-maker
  • A 10% weight-loss refund/credit option is meaningful to you and you'll follow the participation terms
Check Shed eligibility and see real pricing for your route →

60-second intake · HSA/FSA cards accepted · Available in all 50 states per Shed — verify during intake

Pick Hims if:

  • You specifically want branded Wegovy or Ozempic through the direct Novo Nordisk supply chain
  • The app-first experience and async-messaging support are meaningful to you
  • The $149/month membership (after the $39 first month) is acceptable
  • Familiarity and brand recognition of a publicly traded parent matters to you
  • You want the flexibility to cancel the medication plan early (noting the membership cancels separately)
See current Hims pricing and membership details →

Pick neither if:

  • Your insurance covers Wegovy or Zepbound — retail pharmacy with insurance usually beats both self-pay options
  • You need white-glove premium care with included labs and a personal care manager
  • You want the absolute lowest compounded monthly cost and can tolerate more billing complexity — some budget providers undercut both
  • You're on Medicare — the CMS Medicare GLP-1 Bridge program may open specific coverage routes worth exploring before choosing any self-pay telehealth
Take the free 60-second GLP-1 matching quiz →

Cancellation: the friction nobody reads until it’s too late

Hims has the easier cancellation structure overall — but there’s a trap: cancelling your Hims medication plan does not cancel your Hims Weight Loss Membership. Those are two separate cancellations. The $149/month membership can continue billing monthly until you cancel that line too.
Shed requires a 2-month minimum before cancellation and 72-hour notice before the next billing date. If you were going to give a GLP-1 provider at least two months anyway (which most clinicians expect), Shed’s commitment structure doesn’t actually cost you anything extra.

Shed cancellation

  • 2-month minimum commitment from subscription start
  • 72-hour notice before next billing date
  • Refunds not issued once medication has shipped
  • Cancel via patient portal chat or email (no phone call)

Hims cancellation

  • Cancel anytime (2 days before billing date)
  • No minimum term on medication plan
  • Membership cancels separately from medication plan
  • Set a calendar reminder: cancel membership OR the $149/month continues
  • Cancel via app or website (no phone call required)

About Shed’s 10% weight-loss refund/credit

Shed advertises a 10%-body-weight-loss program that can qualify eligible users for a refund or program credit if they fully comply and don’t reach the 10% mark within 9 months. Qualifying terms include weekly time-stamped weight logs, monthly check-ins, coaching and community-program participation where applicable, first-time-use limits, and refund amounts limited to subscription/eligible service fees paid minus any discounts. Final eligibility is at Shed’s discretion per the terms. It’s a real option for committed users — it is not a no-strings money-back guarantee.

The honest take on Shed’s 2-month minimum: Shed does not have the lowest-friction cancellation policy. If the single most important thing to you is being able to cancel a prescription subscription within the first month with no strings, Hims is better on that specific point. But the 2-month commitment is structured around the clinical reality that GLP-1 weight loss takes several weeks to show — the first weeks are primarily dose titration and GI adjustment, not meaningful fat loss. If you were going to give any GLP-1 provider at least two months anyway, Shed’s commitment doesn’t cost you anything.
Commit to 2 months and get Shed’s full format menu →Cancel-anytime flexibility → See Hims membership →

Does Shed or Hims take HSA/FSA?

Shed: direct HSA/FSA card at checkout

  • HSA and FSA cards accepted directly at checkout for prescription purchases
  • Plan-specific eligibility and documentation requirements may vary
  • Confirm with your plan administrator before assuming full coverage

Hims: typically a reimbursement workflow

  • Hims FAQ typically directs customers to pay with a regular card and submit for HSA/FSA reimbursement
  • Eligibility and coverage vary by plan
  • Both approaches can reach the same end result; the workflow difference is real if you have a December FSA deadline

If you have an FSA with a “use it or lose it” December deadline, or an HSA balance you actively manage, the difference between direct card checkout and reimbursement workflow matters. See our dedicated guide: How Shed’s HSA/FSA checkout works →

Use your HSA/FSA card directly → Start Shed intakeSee Hims and plan your reimbursement workflow →

State availability: Shed vs Hims

Shed

Available in all 50 U.S. states (not Puerto Rico) per Shed’s Get Started help page. Consistent across public pages reviewed. Verified April 18, 2026.

Hims

Hims weight-loss page notes “Not available in all 50 states” under prescription disclosures. Specific restrictions depend on medication and formulation. Verify your state during Hims intake for the exact medication you want.

State availability can shift faster than any comparison page updates. Both providers check your state before you complete intake.

Is Shed legit? The trust audit

Short answer: yes for both. Shed is a LegitScript-certified telehealth platform with broadly positive customer-service sentiment on Trustpilot. Hims is a publicly traded company (NYSE: HIMS) with significant scale, a direct Novo Nordisk partnership, and documented regulatory history including an FDA warning letter dated September 9, 2025 over compounded semaglutide marketing claims. Both are legitimate. Both have issues a reasonable buyer should weigh.

Shed trust signals

  • LegitScript telehealth certification
  • 10%-body-weight-loss program with refund/credit eligibility
  • Active Trustpilot profile with high-volume reviews
  • Pharmacy sourcing disclosures (Certificates of Analysis in help pages)
  • BBB listing (Arizona; not accredited)

No current FDA warning letter as of April 18, 2026.

Hims trust signals

  • Publicly traded (NYSE: HIMS), SEC disclosure requirements
  • Direct Novo Nordisk partnership signed March 9, 2026
  • Large self-reported weight-loss customer base
  • App-based care with measurable customer-service data
  • FDA warning letter Sept 9, 2025 (marketing claims, compounded semaglutide)

Our final verdict

For most self-pay readers: Shed

Weight-loss-specific provider, five GLP-1 delivery formats, Foundayo on the platform, direct HSA/FSA checkout, all-50-state availability language, and a 10% weight-loss refund/credit option. The 2-month minimum is the tradeoff — plan for it, and it doesn’t cost you anything if you were giving any GLP-1 provider at least two months anyway.

Check Shed eligibility now →

For branded Wegovy/Ozempic buyers: Hims

Direct Novo Nordisk supply, $188 all-in first month on Wegovy pill, polished app experience, and no minimum term on the medication plan. Know the membership jump ($39 → $149/month) is coming, and cancel the membership separately from the medication plan.

See Hims pricing and membership →

Still not sure which GLP-1 program is right for you?

Four questions about your route preference, budget range, cancellation tolerance, and state. Returns a personalized recommendation across our full provider set — not just Shed and Hims. Free, no email required.

Take the free 60-second matching quiz

Sources

  1. Shed weight-loss category page, tryshed.com, verified April 18, 2026.
  2. Shed Foundayo product page + Shed PRNewswire release, "Shed Adds Foundayo™ to Its Platform," April 15, 2026.
  3. Hims Weight Loss FAQ, hims.com/weight-loss/faq, verified April 18, 2026.
  4. Hims main Weight Loss page, hims.com/weight-loss, verified April 18, 2026.
  5. Novo Nordisk / Hims & Hers joint announcement, "Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers," March 9–26, 2026.
  6. Shed FSA/HSA help page, tryshed.com/resources/help/fsa-hsa, verified April 18, 2026.
  7. Shed subscription/cancellation help pages, tryshed.com, verified April 18, 2026.
  8. Hims investor relations release, "Hims & Hers strategic shift to offer FDA-approved Novo Nordisk GLP-1s," March 9, 2026.
  9. Fierce Healthcare, "Hims & Hers plans to launch $49 copy of Wegovy pill," February 5, 2026.
  10. Healthline, "FDA Blocks Hims & Hers $49 Compounded Wegovy Pill," February 10, 2026.
  11. FDA press announcement, "FDA intends to take action against non-FDA-approved GLP-1 drugs," February 2026.
  12. FDA press release, "FDA releases warning letters to telehealth companies marketing compounded GLP-1 products," March 3, 2026.
  13. FDA press release, "FDA Approves Foundayo (orforglipron)," and Eli Lilly investor release, April 1, 2026.
  14. FDA warning letter, "Hims & Hers Health, Inc. dba Hims, Warning Letter 716567-09092025," September 9, 2025.
  15. Hims Wegovy/Ozempic product and pricing pages, hims.com, verified April 18, 2026.
  16. Shed Wegovy product page, tryshed.com/products/product/wegovy, verified April 18, 2026.
  17. Shed GLP-1 Injections product page, tryshed.com/products/product/glp-1-injections, verified April 18, 2026.
  18. Shed Zepbound page, tryshed.com, verified April 18, 2026.
  19. CMS Medicare GLP-1 Bridge program information, cms.gov, current as of April 2026.
  20. Shed legal terms and 10% program eligibility terms, tryshed.com/resources/legal/terms, verified April 18, 2026.

What we did not verify

  • We did not complete a live checkout on either platform — we read posted pricing, we did not place an order.
  • We did not verify every state-specific medication restriction individually.
  • We did not independently test Shed’s 10% refund/credit program end-to-end.

We re-verify pricing and availability monthly.

Affiliate & editorial disclosure

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission when you start a program through partner links, which supports our verification and publishing costs. Our editorial recommendations are based on verified pricing, regulatory standing, and reader fit — not commission rates.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription treatments requiring evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved as finished products. Always consult a qualified healthcare professional before starting any weight-loss treatment.

Published April 18, 2026. Last verified April 18, 2026. We re-verify pricing and availability monthly.

Frequently asked questions: Shed vs Hims for weight loss

On compounded semaglutide, yes at the starter tier — Shed starts at $199/month, while Hims' main weight-loss path now emphasizes FDA-approved medications plus a $149/month membership ($39 first month), making the all-in month-two cost for comparable Hims routes $238–$338. On branded Wegovy pill, Hims is cheaper in month one ($188 all-in) and roughly $298/month from month two once the membership steps up. Verify your specific route at intake.

No. The Hims Weight Loss Membership is billed separately from medication. Month one is $39, month two and beyond is $149/month, and the medication is a separate line item on top of that.

Not under standard subscription terms. Shed's help pages state that subscriptions require a 2-month minimum before cancellation, with requests submitted at least 72 hours before the next billing date.

You can submit a cancellation anytime, but Hims generally requires cancellation at least 2 days before the next billing date to avoid the next charge, and cancelling the medication plan does not automatically cancel the Hims Weight Loss Membership — those are two separate cancellations.

Shed's help page says it accepts HSA and FSA cards directly at checkout for prescription purchases, with plan-specific eligibility and documentation requirements that may vary. Hims typically directs customers to pay with a regular card and submit for reimbursement.

Yes. FDA approved Foundayo (orforglipron) on April 1, 2026. It's indicated for adults with obesity, or overweight with at least one weight-related comorbid condition, alongside a reduced-calorie diet and increased physical activity. Lilly's cash-pay starter price is $149/month; telehealth pricing varies by provider.

Not as of April 18, 2026. Shed added Foundayo to its platform on April 15, 2026. Hims has not listed Foundayo on its weight-loss pages as of our verification date.

Shed. Shed offers four non-injection GLP-1 options — the FDA-approved Foundayo pill, the Wegovy pill (via brand pathway), sublingual drops, sublingual lozenges, and compounded oral tablets. Hims offers the Wegovy pill as its only oral GLP-1 option.

No. Hims' weight-loss page notes 'Not available in all 50 states' under prescription disclosures. Specific restrictions depend on which medication and formulation you're asking about. Always verify your state during intake. Shed, by contrast, publishes all-50-state language in its help center (excluding Puerto Rico).

Part of Weight Loss Provider Guide’s GLP-1 provider comparison series. Last verified April 18, 2026.

Best GLP-1 providers 2026Shed GLP-1 reviewsIs Shed legit?Shed vs EdenShed vs MEDViEden vs NoomIs Eden legit?Eden pricingDoes Shed accept HSA/FSA?Cheapest GLP-1 without insuranceFoundayo reviewsRo review
Check Shed availability in your state